Evidence map›Paper›PMID 41669459›Full record

ArticleQuantitative imaging in medicine and surgery2026

Xiao Zhong, Junjun Cheng, Yiqiao Luo, Wei Zhang, Minggang Su

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Quantitative imaging in medicine and surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Xiao ZhongDepartment of Nuclear Medicine, West China Hospital, Sichuan University, Chengdu, China.ORCID https://orcid.org/0000-0002-1257-8315
Junjun ChengDepartment of Nuclear Medicine, West China Hospital, Sichuan University, Chengdu, China.
Yiqiao LuoCancer Center, West China Hospital, Sichuan University, Chengdu, China.
Wei ZhangWest China Biomedical Big Data Center, West China Hospital, Sichuan University, Chengdu, China.
Minggang SuDepartment of Nuclear Medicine, West China Hospital, Sichuan University, Chengdu, China.ORCID https://orcid.org/0000-0001-7617-7302

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Previous studies indicate that renal fibroblast activation protein expression inversely correlates with kidney function and that gallium-68 fibroblast activation protein inhibitor ( Methods: Patients who underwent whole-body Results: A total of 145 patients (82 men; mean age: 59.3±11.27 years; range, 23-83 years) were included. The SUVmax of renal cortex and eGFR was negatively correlated (R Conclusions: The concentration of

Indexed as

diagnosisGallium-68-labeled fibroblast activation protein inhibitor (68Ga-FAPI)kidney diseasepositron emission tomography/computed tomography (PET/CT)prediction

Identifiers

PMID41669459
PMCPMC12883434

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.